Le Lézard
Classified in: Health
Subject: PDT

SCbio's Life Science Accelerator, SCbioDrive, Launches Application for Inaugural Cohort


GREENVILLE, S.C., May 7, 2024 /PRNewswire/ -- SCbio, in partnership with The Massachusetts Biotechnology Council (MassBio), today opened the applications for its new accelerator program, SCbioDrive, A biannual program, SCbioDrive will select up to six seed-stage life sciences companies for an eight-week hybrid program designed to advance their platforms and technologies through expert business curricula, industry guidance and mentorship - all at no cost.

Emerging therapeutics companies are invited to apply for the inaugural Fall 2024 program by June 28.

Startups selected through a rigorous two-step vetting process will:

"The resources and knowledge that the SCbioDrive inaugural cohort will gain from the expert companies leading this curriculum will be invaluable," said SCbio President and CEO James Chappell. "We want this program to show entrepreneurs that South Carolina is the state where businesses, at their earliest stages, are set up for success and sustained growth."

"Our vision for Drive has always been to support diverse founders with exciting science no matter where they are starting their company," said MassBio CEO & President Kendalle Burlin O'Connell. "We're pleased to see SCbio take the MassBioDrive model and put a Palmetto State spin on it to accelerate their homegrown startups toward success."

The Fall 2024 accelerator will run from September 23 to November 21. Applications for the inaugural program cohort are available at www.scbio.org/scbiodrive.  

SCbio is South Carolina's investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. SCbio represents more than 1,000 organizations employing more than 87,000 professionals across the state and supports and advances organizations in multiple arenas including pharmaceuticals, medical devices and equipment, digital health, research and medical labs, bioscience distribution, bio-ag and more. For additional information about SCbio and the life sciences industry, visit www.SCbio.org.

SOURCE SCbio


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: